Iaso Biomed, Inc. (1662907) SEC Filing 8-K Material Event for the period ending Thursday, March 1, 2018

Iaso Biomed, Inc.

CIK: 1662907

View differences made from one to another to evaluate Iaso Biomed, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Iaso Biomed, Inc..


Assess how Iaso Biomed, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Iaso Biomed, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1662907
Form Type: 8-K Corporate News
Accession Number: 0001511164-18-000130
Submitted to the SEC: Wed Mar 07 2018 2:52:33 PM EST
Accepted by the SEC: Wed Mar 07 2018
Period: Thursday, March 1, 2018
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. New Agreement

External Resources:

Bookmark the Permalink: